<http://webisa.webdatacommons.org/328344483>	<http://www.w3.org/ns/prov#value>	"obtaining FDA and other regulatory approvals, and risks related to the viability of and potential alternative treatments in any future target markets. 4." .
<http://webisa.webdatacommons.org/prov/331507217>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/328344483> .
<http://webisa.webdatacommons.org/328344483>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<financialcontent.com> .
<http://webisa.webdatacommons.org/328344483>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .